Carboplatin Injection, Solution
Product Images NDC 61703-360

11 FDA label images from Hospira, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Carboplatin (NDC 61703-360). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Carboplatin 01)

Chemical Structure (Carboplatin 01)
Chemical structure of Carboplatin showing its platinum core bonded to amine groups and a cyclobutane dicarboxylate ligand.*
FDA Label Image

Logo (Carboplatin 02)

FDA Label Image

Logo (Carboplatin 03)

FDA Label Image

Principal Display Panel (5 mL Vial Label)

Principal Display Panel (5 mL Vial Label)
Label for Carboplatin Injection 50 mg/5 mL (10 mg/mL) in a 5 mL multiple-dose vial. The label indicates the product is sterile, for intravenous use only, and is a cytotoxic agent. It shows the labeler as Hospira Worldwide, Inc., includes storage instructions, and displays an NDC number 61703-360-18 along with a barcode and QR code.*
FDA Label Image

Principal Display Panel (5 mL Vial Carton)

Principal Display Panel (5 mL Vial Carton)
Packaging label for Carboplatin Injection 50 mg per 5 mL (10 mg/mL) multiple-dose vial. The label features dosage information, storage instructions, and warnings including 'Cytotoxic Agent' in red bands. Distributed by Hospira, Inc., with manufacturing noted in Germany and branding by Novaplus.*
FDA Label Image

Principal Display Panel (15 mL Vial Label)

Principal Display Panel (15 mL Vial Label)
Label for Carboplatin Injection, 150 mg per 15 mL (10 mg/mL) in a 15 mL multiple-dose vial for intravenous use. The label states it is a cytotoxic agent, contains no preservatives, and provides storage directions. Distributed by Hospira Worldwide, Inc. The label includes NDC 61703-150-05 and the branding Novaplus.*
FDA Label Image

Principal Display Panel (15 mL Vial Carton)

Principal Display Panel (15 mL Vial Carton)
Packaging label for Carboplatin Injection 150 mg/15 mL (10 mg/mL) multiple-dose vial, distributed by Hospira, Inc. The label includes storage instructions, lot number placeholder, and a warning that it is a cytotoxic agent. The vial content details and usage instructions are printed on the carton, which is marked with a barcode and the Novaplus trademark.*
FDA Label Image

Principal Display Panel (45 mL Vial Label)

Principal Display Panel (45 mL Vial Label)
Carboplatin Injection 450 mg/45 mL (10 mg/mL) multiple-dose vial label. The label indicates it is for intravenous use and is a cytotoxic agent. It includes storage instructions, company contact information, and distributor details for Hospira, Inc. The label also highlights the presence of carboplatin USP and water for injection USP, and contains a lot and expiration date section.*
FDA Label Image

Principal Display Panel (45 mL Vial Carton)

Principal Display Panel (45 mL Vial Carton)
Carboplatin Injection 450 mg/45 mL (10 mg/mL) vial packaging label from Hospira Worldwide, Inc. The label indicates a sterile, multiple-dose vial for intravenous use. It includes storage instructions to keep the vial at 25°C with permitted excursions and a warning that the product contains no preservatives. The packaging highlights the product as a cytotoxic agent and notes it is made in Germany and distributed by Hospira, Inc.*
FDA Label Image

Principal Display Panel (60 mL Vial Label)

Principal Display Panel (60 mL Vial Label)
Label for Carboplatin Injection 600 mg/60 mL (10 mg/mL) sterile solution in a 60 mL multiple-dose vial. The label indicates it is for intravenous use and is a cytotoxic agent. It includes storage instructions, lot number, expiration date, and distributor information for Hospira Worldwide, Inc., with references to preservative status and handling precautions.*
FDA Label Image

Principal Display Panel (60 mL Vial Carton)

Principal Display Panel (60 mL Vial Carton)
Carboplatin Injection 600 mg/60 mL (10 mg/mL) in a multiple-dose vial, labeled for intravenous use. The carton indicates the product is distributed by Hospira, Inc. and made in Germany. The label includes a warning for cytotoxic agent and storage instructions at 25°C with protections from light. The NDC number visible is 61703-600-05.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.